A detailed history of Foundry Partners, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Foundry Partners, LLC holds 2,970 shares of LNTH stock, worth $268,844. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,970
Previous 6,075 51.11%
Holding current value
$268,844
Previous $487,000 33.26%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$77.7 - $123.62 $241,258 - $383,840
-3,105 Reduced 51.11%
2,970 $325,000
Q2 2024

Aug 05, 2024

BUY
$58.87 - $83.05 $357,635 - $504,528
6,075 New
6,075 $487,000
Q4 2023

Feb 01, 2024

BUY
$55.6 - $77.89 $4.11 Million - $5.76 Million
73,901 New
73,901 $4.58 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.22B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.